Lawmakers Press FDA to Target Knockoff Weight-Loss Drugs (2)

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market — a problem that emerged over the last year.

“We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications,” they wrote in a letter to FDA Commissioner Marty Makary. “Undoubtedly, illegal counterfeit medications ...